4//SEC Filing
Meyers Steve Lawrence 4
Accession 0001104659-26-001295
CIK 0001393434other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:06 PM ET
Size
7.8 KB
Accession
0001104659-26-001295
Insider Transaction Report
Form 4
Meyers Steve Lawrence
Chief Commercial Officer
Transactions
- Award
Common Stock
2026-01-02+64,900→ 217,628 total - Award
Stock Option (Right to Buy)
2026-01-02+197,650→ 197,650 totalExercise: $11.82Exp: 2036-01-01→ Common Stock (197,650 underlying)
Footnotes (2)
- [F1]On January 2, 2026, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter.
- [F2]Subject to the reporting person's continued service to the Corporation, the shares underlying this option vest over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.
Documents
Issuer
OCULAR THERAPEUTIX, INC
CIK 0001393434
Entity typeother
Related Parties
1- filerCIK 0002073994
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:06 PM ET
- Size
- 7.8 KB